Epinephrine
Hemophilia
University of MinnesotaSmall moleculeEarly Phase 1Active
C
38/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 24/ 100
- Competitive Position
- 81/ 100
Competitive context
15 Active assets in the Hemophilia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Rfviii Chulalongkorn University | Phase 4 | BB |
Stsp-0601 For Jiangsu BioJeTay Biotechnology Co., Ltd. | Phase 3 | BB |
Ribavirin Kenneth Sherman | Phase 4 | BB |
Pegylated Interferon Alpha2A Baqiyatallah Medical Sciences University | Phase 4 | BB |
Eptacog Alfa Laboratoire français de Fractionnement et de Biotechnologies | Phase 3 | BB |
View all 37 →
Same molecule, other indications
Epinephrine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →